Terry Farsani, MD
Dermatology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
- Since medical school
- 16 years
- University of California, San Francisco School of Medicine, 2010
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Farsani’s office at (408) 934-7000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A130247 · Current
Licensed to practise in California · since 2014 · expires 2028-05-31 · University of California San Francisco School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Dermatology - Dermatology
Original Medicare doctor bills
$146,487
Medicare paid this office $146,487 for 438 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 326 | $35,476 | $74 |
| Destruction of precancer skin growth, 15 or more growths | 87 | $19,677 | $160 |
| Destruction of skin growth, 1-14 growths | 129 | $16,718 | $110 |
| Destruction of precancer skin growth, 1 growth | 217 | $14,340 | $50 |
| Return visit (30+ min) | 106 | $13,867 | $106 |
See all 10 services
| Short return visit (20+ min) | 326 | $35,476 | $74 |
| Destruction of precancer skin growth, 15 or more growths | 87 | $19,677 | $160 |
| Destruction of skin growth, 1-14 growths | 129 | $16,718 | $110 |
| Destruction of precancer skin growth, 1 growth | 217 | $14,340 | $50 |
| Return visit (30+ min) | 106 | $13,867 | $106 |
| Biopsy of related skin growth, first growth | 114 | $12,293 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 185 | $9,188 | $7 |
| Biopsy of related skin growth, each additional growth | 28 | $2,776 | $52 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $2,020 | $155 |
| Application of ultraviolet light to skin | 20 | $1,305 | $26 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 14 | More than 69% of doctors who do this |
| Removal of skin lesions | 554 | More than 88% of doctors who do this |
| Skin biopsy | 146 | More than 81% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 520 | 602 | 831 | 1,180 | 1,334 | 1,343 |
| Destruction of precancer skin growth, 1 growth | 159 | 171 | 241 | 292 | 317 | 289 |
| Destruction of skin growth, 1-14 growths | 110 | 113 | 173 | 139 | 209 | 152 |
| Biopsy of related skin growth, first growth | 90 | 82 | 143 | 181 | 161 | 141 |
| Destruction of precancer skin growth, 15 or more growths | 62 | 51 | 86 | 112 | 116 | 123 |
| Biopsy of related skin growth, each additional growth | 29 | 27 | 36 | 81 | 61 | 53 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
438 Original Medicare patients in 2024. Average age 76 · Women 53% · Also on Medicaid 4% · Health risk score 0.92. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 63% · Coronary heart disease 24% · Cancer 18% · Chronic kidney disease 16% · Atrial fibrillation 14% · Diabetes 13% · Depression 13% · Heart failure 10% · COPD 5% · Stroke 4% · Dementia 3%.
The office billed $539,019, Medicare allowed $203,688 and paid $146,487; for 2,910 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 438 | 2,910 | 76 | 0.92 | $539,019 | $146,487 |
| 2023 | 484 | 3,165 | 77 | 0.90 | $590,255 | $174,646 |
| 2022 | 507 | 2,946 | 77 | 0.84 | $545,782 | $163,445 |
| 2021 | 435 | 2,477 | 76 | 0.86 | $507,319 | $157,835 |
| 2020 | 362 | 1,751 | 75 | 0.95 | $339,779 | $97,705 |
| 2019 | 339 | 1,643 | 75 | 0.97 | $357,049 | $104,861 |
| 2018 | 381 | 2,063 | 76 | 0.99 | $397,031 | $114,761 |
| 2017 | 310 | 1,587 | 75 | 1.00 | $372,467 | $98,198 |
| 2016 | 354 | 1,672 | 76 | 1.07 | $344,084 | $97,755 |
| 2015 | 225 | 878 | 74 | 0.92 | $167,280 | $50,378 |
| 2014 | 75 | 203 | 74 | 0.94 | $44,484 | $14,065 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Short return visit (20+ min) | 340 | $37,316 | $77 |
| Destruction of skin growth, 1-14 growths | 154 | $23,630 | $113 |
| Destruction of precancer skin growth, 15 or more growths | 86 | $19,391 | $167 |
| Destruction of precancer skin growth, 1 growth | 243 | $15,680 | $49 |
| Return visit (30+ min) | 131 | $15,662 | $108 |
| Biopsy of related skin growth, first growth | 133 | $15,035 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 207 | $9,564 | $7 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 13 | $5,590 | $430 |
| Biopsy of related skin growth, each additional growth | 33 | $3,211 | $53 |
| Application of ultraviolet light to skin | 26 | $2,368 | $28 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 16 | $2,249 | $132 |
| New patient visit (30+ min) | 23 | $2,245 | $98 |
| Punch biopsy, first skin growth | 14 | $2,026 | $127 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,404 | $128 |
| Short return visit | 13 | $739 | $53 |
2022: 15 services
| Short return visit (20+ min) | 318 | $34,185 | $75 |
| Return visit (30+ min) | 143 | $19,831 | $111 |
| Destruction of precancer skin growth, 15 or more growths | 81 | $19,032 | $170 |
| Biopsy of related skin growth, first growth | 147 | $17,131 | $95 |
| Destruction of skin growth, 1-14 growths | 118 | $15,570 | $112 |
| Destruction of precancer skin growth, 1 growth | 222 | $14,773 | $51 |
| Destruction of precancer skin growth, 2-14 growths | 189 | $8,180 | $7 |
| Biopsy of related skin growth, each additional growth | 48 | $4,178 | $52 |
| New patient visit (30+ min) | 36 | $3,198 | $89 |
| Punch biopsy, first skin growth | 19 | $2,424 | $121 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 12 | $2,010 | $155 |
| New patient visit (45+ min) | 16 | $1,961 | $123 |
| Application of ultraviolet light to skin | 15 | $1,428 | $25 |
| Short return visit | 17 | $841 | $49 |
| New patient visit (15+ min) | 11 | $491 | $45 |
2021: 14 services
| Short return visit (20+ min) | 233 | $27,765 | $77 |
| Return visit (30+ min) | 174 | $24,445 | $104 |
| Destruction of skin growth, 1-14 growths | 138 | $20,140 | $116 |
| Destruction of precancer skin growth, 15 or more growths | 62 | $14,710 | $171 |
| Biopsy of related skin growth, first growth | 115 | $13,712 | $96 |
| Destruction of precancer skin growth, 1 growth | 171 | $11,732 | $49 |
| Destruction of precancer skin growth, 2-14 growths | 141 | $5,861 | $7 |
| New patient visit (30+ min) | 43 | $3,952 | $92 |
| New patient visit (45+ min) | 26 | $3,142 | $121 |
| Punch biopsy, first skin growth | 15 | $2,169 | $136 |
| Biopsy of related skin growth, each additional growth | 27 | $2,028 | $56 |
| Short return visit | 26 | $1,721 | $54 |
| Injection into skin growth, 1-7 growths | 12 | $1,287 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $58 | None |
2020: 14 services
| Return visit (30+ min) | 218 | $26,726 | $93 |
| Destruction of skin growth, 1-14 growths | 91 | $12,168 | $108 |
| Short return visit (20+ min) | 139 | $12,064 | $59 |
| Destruction of precancer skin growth, 1 growth | 129 | $8,244 | $48 |
| Destruction of precancer skin growth, 15 or more growths | 46 | $8,071 | $158 |
| Biopsy of related skin growth, first growth | 70 | $7,116 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 110 | $3,852 | $6 |
| New patient visit (30+ min) | 27 | $2,104 | $78 |
| Punch biopsy, first skin growth | 13 | $1,664 | $119 |
| Biopsy of related skin growth, each additional growth | 19 | $1,457 | $54 |
| New patient visit (15+ min) | 16 | $625 | $39 |
| Application of ultraviolet light to skin | 12 | $596 | $22 |
| Injection into skin growth, 1-7 growths | 12 | $512 | $43 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $27 | None |
2019: 11 services
| Return visit (30+ min) | 193 | $23,987 | $98 |
| Short return visit (20+ min) | 136 | $12,336 | $69 |
| Destruction of skin growth, 1-14 growths | 91 | $12,206 | $111 |
| Destruction of precancer skin growth, 15 or more growths | 55 | $9,339 | $151 |
| Biopsy of related skin growth, first growth | 77 | $8,210 | $91 |
| Destruction of precancer skin growth, 1 growth | 126 | $7,824 | $49 |
| New patient visit (30+ min) | 52 | $5,054 | $97 |
| Destruction of precancer skin growth, 2-14 growths | 98 | $2,932 | $6 |
| Punch biopsy, first skin growth | 15 | $1,900 | $119 |
| Biopsy of related skin growth, each additional growth | 17 | $1,537 | $53 |
| New patient visit (15+ min) | 22 | $1,508 | $69 |
2018: 12 services
| Return visit (30+ min) | 183 | $25,588 | $94 |
| Short return visit (20+ min) | 188 | $15,652 | $59 |
| Destruction of skin growth, 1-14 growths | 102 | $13,378 | $107 |
| Destruction of precancer skin growth, 15 or more growths | 60 | $11,176 | $136 |
| Biopsy of single growth of skin and/or tissue | 105 | $11,049 | $93 |
| Destruction of precancer skin growth, 1 growth | 155 | $9,332 | $49 |
| New patient visit (30+ min) | 91 | $7,532 | $83 |
| Destruction of precancer skin growth, 2-14 growths | 121 | $3,449 | $5 |
| New patient visit (15+ min) | 18 | $1,056 | $59 |
| Biopsy of each additional growth of skin and/or tissue | 25 | $996 | $30 |
| Application of ultraviolet light to skin | 13 | $668 | $22 |
| Short return visit | 13 | $538 | $41 |
2017: 12 services
| Return visit (30+ min) | 146 | $16,432 | $80 |
| Short return visit (20+ min) | 133 | $10,386 | $58 |
| Biopsy of single growth of skin and/or tissue | 84 | $9,315 | $93 |
| Destruction of precancer skin growth, 15 or more growths | 48 | $9,288 | $139 |
| Destruction of skin growth, 1-14 growths | 57 | $7,009 | $105 |
| Destruction of precancer skin growth, 1 growth | 108 | $6,823 | $51 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 14 | $6,213 | $414 |
| New patient visit (30+ min) | 78 | $5,927 | $76 |
| Destruction of precancer skin growth, 2-14 growths | 80 | $2,420 | $5 |
| Application of ultraviolet light to skin | 17 | $1,607 | $19 |
| Biopsy of each additional growth of skin and/or tissue | 21 | $890 | $31 |
| New patient visit (15+ min) | 14 | $714 | $51 |
2016: 12 services
| Return visit (30+ min) | 177 | $23,701 | $91 |
| Destruction of precancer skin growth, 15 or more growths | 57 | $12,334 | $143 |
| Biopsy of single growth of skin and/or tissue | 109 | $11,654 | $93 |
| New patient visit (30+ min) | 85 | $7,474 | $88 |
| Destruction of skin growth, 1-14 growths | 61 | $7,123 | $99 |
| Destruction of precancer skin growth, 1 growth | 122 | $7,118 | $47 |
| Short return visit (20+ min) | 94 | $6,724 | $58 |
| New patient visit (15+ min) | 59 | $3,126 | $53 |
| Destruction of precancer skin growth, 2-14 growths | 94 | $2,684 | $5 |
| Biopsy of each additional growth of skin and/or tissue | 31 | $1,378 | $31 |
| Application of ultraviolet light to skin | 15 | $1,322 | $22 |
| Short return visit | 11 | $343 | $31 |
2015: 11 services
| Return visit (30+ min) | 92 | $11,069 | $95 |
| Destruction of skin growth, 1-14 growths | 52 | $6,123 | $111 |
| Biopsy of single growth of skin and/or tissue | 46 | $5,011 | $100 |
| Short return visit (20+ min) | 62 | $4,716 | $65 |
| Destruction of precancer skin growth, 1 growth | 75 | $4,709 | $54 |
| New patient visit (30+ min) | 64 | $4,648 | $73 |
| Destruction of precancer skin growth, 15 or more growths | 22 | $3,795 | $152 |
| New patient visit (15+ min) | 45 | $2,855 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 65 | $1,603 | $6 |
| Short return visit | 18 | $750 | $42 |
| Biopsy of each additional growth of skin and/or tissue | 14 | $699 | $32 |
2014: 6 services
| Return visit (30+ min) | 28 | $2,902 | $100 |
| New patient visit (30+ min) | 29 | $2,761 | $95 |
| Biopsy of single growth of skin and/or tissue | 18 | $1,686 | $94 |
| Short return visit (20+ min) | 20 | $1,567 | $68 |
| Destruction of skin growth, 1-14 growths | 12 | $1,295 | $108 |
| Destruction of precancer skin growth, 1 growth | 13 | $837 | $56 |
Drugs they prescribed that Part D paid
$189,160
Pharmacies billed $189,160 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 467) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
423 generic and 44 brand-name prescriptions · $189,160 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 14 | $97,713 | $6,980 |
| Dupixent | 21 | $79,693 | $3,795 |
| Fluorouracil | 34 | $2,055 | $60 |
| Ketoconazole | 64 | $1,377 | $22 |
| Metronidazole | 30 | $1,219 | $41 |
See all 16 drugs
| Humira(Cf) | 14 | $97,713 | $6,980 |
| Dupixent | 21 | $79,693 | $3,795 |
| Fluorouracil | 34 | $2,055 | $60 |
| Ketoconazole | 64 | $1,377 | $22 |
| Metronidazole | 30 | $1,219 | $41 |
| Betamethasone Dipropionate | 14 | $547 | $39 |
| Clobetasol Propionate | 26 | $489 | $19 |
| Betamethasone Diprop Augmented | 20 | $433 | $22 |
| Fluocinonide | 16 | $328 | $20 |
| Minoxidil | 23 | $250 | $11 |
| Mupirocin | 26 | $218 | $8 |
| Spironolactone | 13 | $191 | $15 |
| Valacyclovir | 14 | $152 | $11 |
| Hydrocortisone | 24 | $149 | $6 |
| Nystatin | 13 | $129 | $10 |
| Triamcinolone Acetonide | 15 | $55 | $4 |
Year by year
| 2024 | 467 | 184 | 0% (0) | 9% | $189,160 |
| 2023 | 473 | 206 | 0% (0) | None | $172,707 |
| 2022 | 537 | 206 | 0% (0) | None | $119,155 |
| 2021 | 608 | 218 | 0% (0) | 14% | $120,359 |
| 2020 | 520 | 195 | 0% (0) | 12% | $97,519 |
| 2019 | 400 | 157 | 0% (0) | 15% | $62,818 |
| 2018 | 505 | 192 | 0% (0) | 15% | $76,561 |
| 2017 | 334 | 129 | None | 9% | $19,631 |
| 2016 | 354 | 150 | 0% (0) | 11% | $24,068 |
| 2015 | 211 | 106 | 0% (0) | 20% | $17,521 |
| 2014 | 117 | 66 | 0% (0) | 20% | $10,470 |
| 2013 | 133 | 55 | 0% (0) | 17% | $17,258 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Humira(Cf) | 14 | $97,713 | $6,980 |
| Dupixent | 13 | $59,374 | $4,567 |
| Fluorouracil | 41 | $3,289 | $80 |
| Ketoconazole | 87 | $2,307 | $27 |
| Metronidazole | 25 | $1,995 | $80 |
| Betamethasone Dipropionate | 17 | $1,233 | $73 |
| Clobetasol Propionate | 23 | $1,124 | $49 |
| Ciclopirox | 24 | $715 | $30 |
| Betamethasone Diprop Augmented | 31 | $656 | $21 |
| Doxycycline Monohydrate | 11 | $530 | $48 |
| Mupirocin | 26 | $250 | $10 |
| Nystatin | 11 | $166 | $15 |
| Hydrocortisone | 30 | $141 | $5 |
| Terbinafine | 13 | $117 | $9 |
| Spironolactone | 15 | $109 | $7 |
| Triamcinolone Acetonide | 20 | $78 | $4 |
2022: 16 drugs
| Humira(Cf) | 14 | $90,031 | $6,431 |
| Fluorouracil | 51 | $5,265 | $103 |
| Clobetasol Propionate | 35 | $3,210 | $92 |
| Ketoconazole | 66 | $2,344 | $36 |
| Betamethasone Diprop Augmented | 52 | $1,668 | $32 |
| Metronidazole | 17 | $1,347 | $79 |
| Ciclopirox | 25 | $1,022 | $41 |
| Betamethasone Dipropionate | 13 | $903 | $69 |
| Fluocinonide | 15 | $794 | $53 |
| Clindamycin Phosphate | 12 | $786 | $66 |
| Nystatin | 17 | $408 | $24 |
| Mupirocin | 39 | $395 | $10 |
| Valacyclovir | 16 | $229 | $14 |
| Hydrocortisone | 36 | $195 | $5 |
| Triamcinolone Acetonide | 26 | $116 | $4 |
| Terbinafine | 11 | $82 | $7 |
2021: 15 drugs
| Humira(Cf) | 14 | $84,244 | $6,017 |
| Fluorouracil | 41 | $4,243 | $103 |
| Betamethasone Diprop Augmented | 61 | $3,347 | $55 |
| Ketoconazole | 85 | $3,060 | $36 |
| Clindamycin Phosphate | 23 | $2,958 | $129 |
| Tacrolimus | 19 | $2,443 | $129 |
| Fluocinonide | 38 | $2,145 | $56 |
| Clobetasol Propionate | 30 | $1,914 | $64 |
| Metronidazole | 16 | $1,445 | $90 |
| Nystatin | 22 | $425 | $19 |
| Ciclopirox | 14 | $407 | $29 |
| Mometasone Furoate | 14 | $400 | $29 |
| Mupirocin | 42 | $340 | $8 |
| Hydrocortisone | 38 | $208 | $5 |
| Triamcinolone Acetonide | 37 | $192 | $5 |
2020: 14 drugs
| Fluorouracil | 34 | $3,345 | $98 |
| Betamethasone Diprop Augmented | 55 | $3,207 | $58 |
| Ketoconazole | 75 | $2,288 | $31 |
| Clindamycin Phosphate | 13 | $2,283 | $176 |
| Tacrolimus | 14 | $2,275 | $162 |
| Fluocinonide | 26 | $1,680 | $65 |
| Clobetasol Propionate | 18 | $1,405 | $78 |
| Metronidazole | 19 | $1,226 | $65 |
| Ciclopirox | 13 | $670 | $52 |
| Mupirocin | 51 | $427 | $8 |
| Nystatin | 21 | $341 | $16 |
| Mometasone Furoate | 11 | $276 | $25 |
| Hydrocortisone | 28 | $126 | $5 |
| Triamcinolone Acetonide | 18 | $99 | $5 |
2019: 11 drugs
| Fluorouracil | 29 | $2,863 | $99 |
| Betamethasone Diprop Augmented | 34 | $2,156 | $63 |
| Metronidazole | 16 | $1,721 | $108 |
| Ketoconazole | 44 | $1,521 | $35 |
| Clobetasol Propionate | 12 | $1,386 | $116 |
| Fluocinonide | 24 | $1,286 | $54 |
| Nystatin | 14 | $289 | $21 |
| Mupirocin | 22 | $254 | $12 |
| Cephalexin | 14 | $179 | $13 |
| Triamcinolone Acetonide | 30 | $169 | $6 |
| Hydrocortisone | 30 | $156 | $5 |
2018: 13 drugs
| Betamethasone Diprop Augmented | 54 | $3,986 | $74 |
| Ketoconazole | 67 | $3,528 | $53 |
| Clobetasol Propionate | 23 | $2,865 | $125 |
| Fluorouracil | 17 | $1,710 | $101 |
| Fluocinonide | 27 | $1,585 | $59 |
| Metronidazole | 18 | $1,475 | $82 |
| Nystatin | 19 | $562 | $30 |
| Mupirocin | 26 | $377 | $15 |
| Triamcinolone Acetonide | 46 | $339 | $7 |
| Gabapentin | 11 | $230 | $21 |
| Ranitidine | 11 | $179 | $16 |
| Cephalexin | 11 | $141 | $13 |
| Hydrocortisone | 28 | $127 | $5 |
2017: 8 drugs
| Metronidazole | 32 | $3,235 | $101 |
| Clobetasol Propionate | 14 | $2,885 | $206 |
| Fluocinonide | 32 | $2,309 | $72 |
| Fluorouracil | 19 | $1,895 | $100 |
| Ketoconazole | 38 | $1,518 | $40 |
| Betamethasone Dipropionate | 18 | $961 | $53 |
| Triamcinolone Acetonide | 46 | $448 | $10 |
| Hydrocortisone | 13 | $71 | $5 |
2016: 10 drugs
| Clobetasol Propionate | 28 | $4,674 | $167 |
| Metronidazole | 24 | $2,605 | $109 |
| Econazole Nitrate | 18 | $2,234 | $124 |
| Fluocinonide | 27 | $1,693 | $63 |
| Fluorouracil | 12 | $1,614 | $135 |
| Ketoconazole | 24 | $1,094 | $46 |
| Triamcinolone Acetonide | 43 | $510 | $12 |
| Mupirocin | 30 | $415 | $14 |
| Hydrocortisone | 16 | $171 | $11 |
| Minocycline | 13 | $45 | $3 |
2015: 8 drugs
| Clobetasol Propionate | 27 | $3,822 | $142 |
| Metronidazole | 15 | $2,220 | $148 |
| Fluorouracil | 12 | $1,921 | $160 |
| Desonide | 13 | $1,454 | $112 |
| Fluocinonide | 11 | $919 | $84 |
| Ketoconazole | 21 | $769 | $37 |
| Triamcinolone Acetonide | 34 | $291 | $9 |
| Mupirocin | 17 | $159 | $9 |
2013: 4 drugs
| Clobetasol Propionate | 19 | $2,570 | $135 |
| Methotrexate | 11 | $696 | $63 |
| Triamcinolone Acetonide | 15 | $330 | $22 |
| Econazole Nitrate | 12 | $220 | $18 |
Money from drug and device companies
$886 in 2025
| 2025 | 11 | 42 | None | $886 |
| 2024 | 10 | 12 | None | $431 |
| 2023 | 1 | 1 | None | $15 |
| 2022 | 1 | 1 | None | $108 |
| 2021 | 1 | 1 | None | $72 |
| 2020 | 1 | 1 | None | $116 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $241 | 15 payments
|
| Abbvie | Skyrizi | $136 | 6 payments
|
| Novartis Pharmaceuticals | Cosentyx | $130 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $102 | 5 payments
|
| Pfizer | Cibinqo | $54 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $52 | 2 payments
|
See all 42 published payments
| Regeneron Healthcare Solutions | Meals · 2025-12-17 | Dupixent | $21 |
| Ucb | Meals · 2025-12-16 | Bimzelx | $42 |
| Abbvie | Meals · 2025-12-04 | Skyrizi | $23 |
| Janssen Biotech | Meals · 2025-12-03 | Tremfya | $31 |
| Abbvie | Meals · 2025-11-25 | Skyrizi | $24 |
| Arcutis Biotherapeutics | Meals · 2025-11-25 | Zoryve | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-11-21 | Dupixent | $16 |
| Novartis Pharmaceuticals | Meals · 2025-11-17 | Cosentyx | $24 |
| Abbvie | Meals · 2025-11-07 | Skyrizi | $27 |
| Janssen Biotech | Meals · 2025-10-29 | Tremfya | $7 |
| Janssen Biotech | Meals · 2025-10-28 | Tremfya | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-10-22 | Dupixent | $28 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $6 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $1 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $24 |
| Janssen Biotech | Meals · 2025-10-15 | Tremfya | $2 |
| Lilly USA | Meals · 2025-10-07 | Taltz | $30 |
| Incyte | Meals · 2025-10-03 | Opzelura | $19 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $32 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $2 |
| Galderma Laboratories L.P. | Meals · 2025-09-17 | Nemluvio | $28 |
| Novartis Pharmaceuticals | Meals · 2025-09-16 | Cosentyx | $19 |
| Genzyme | Meals · 2025-09-12 | Dupixent | $35 |
| Janssen Biotech | Meals · 2025-09-09 | Tremfya | $16 |
| Janssen Biotech | Meals · 2025-09-02 | Tremfya | $22 |
| Janssen Biotech | Meals · 2025-08-26 | Tremfya | $6 |
| Abbvie | Meals · 2025-08-22 | Rinvoq | $33 |
| Regeneron Healthcare Solutions | Meals · 2025-07-18 | Dupixent | $15 |
| Novartis Pharmaceuticals | Meals · 2025-05-05 | Cosentyx | $31 |
| Janssen Biotech | Meals · 2025-04-30 | Tremfya | $14 |
| Novartis Pharmaceuticals | Meals · 2025-03-31 | Cosentyx | $17 |
| Novartis Pharmaceuticals | Meals · 2025-03-17 | Cosentyx | $14 |
| Pfizer | Meals · 2025-03-13 | Cibinqo | $29 |
| Lilly USA | Meals · 2025-03-10 | Taltz | $17 |
| Regeneron Healthcare Solutions | Meals · 2025-02-27 | Dupixent | $22 |
| Novartis Pharmaceuticals | Meals · 2025-02-20 | Cosentyx | $25 |
| Janssen Biotech | Meals · 2025-02-06 | Tremfya | $22 |
| Abbvie | Meals · 2025-01-29 | Rinvoq | $7 |
| Abbvie | Meals · 2025-01-29 | Rinvoq | $21 |
| Janssen Biotech | Meals · 2025-01-16 | Tremfya | $34 |
| Pfizer | Meals · 2025-01-16 | Cibinqo | $25 |
| Arcutis Biotherapeutics | Meals · 2025-01-09 | Zoryve | $25 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $431
| Regeneron Healthcare Solutions | Dupixent | $149 | 2 payments
|
| Pfizer | Litfulo | $50 | 2 payments
|
| Galderma Laboratories L.P. | None | $36 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $34 | 1 payment
|
| Abbvie | Skyrizi | $33 | 1 payment
|
| Janssen Biotech | Tremfya | $30 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $28 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $26 | 1 payment
|
| Lilly USA | Taltz | $25 | 1 payment
|
| Verrica Pharmaceuticals | Ycanth | $19 | 1 payment
|
2023: $15
| Pfizer | Cibinqo | $15 | 1 payment
|
2022: $108
| Novartis Pharmaceuticals | Kesimpta | $108 | 1 payment
|
2021: $72
| Novartis Pharmaceuticals | Kesimpta | $72 | 1 payment
|
2020: $116
| Regeneron Healthcare Solutions | None | $116 | 1 payment
|
Professional record
- NPI
- 1750602819
- Licence
- CA 130247California A130247: Current · expires 2028-05-31
- Trained
- University of California, San Francisco School of Medicine, 2010 · 16 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 701 E El Camino Real, Attention: Physician Services, Mountain View, CA, 94040
- NPI first listed
- 2010-06-11
- NPI last updated
- 2014-09-12
This is when the NPI record was last certified, not a medical board exam.